CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 176 filers reported holding CLOVIS ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $6,902,000 | -31.0% | 235,000 | +6.8% | 0.84% | -40.0% |
Q2 2018 | $10,003,000 | +6.7% | 220,000 | +23.9% | 1.40% | -15.1% |
Q1 2018 | $9,372,000 | +8.1% | 177,500 | +39.2% | 1.65% | -21.9% |
Q4 2017 | $8,670,000 | -17.5% | 127,500 | 0.0% | 2.11% | -28.9% |
Q3 2017 | $10,506,000 | -13.7% | 127,500 | -1.9% | 2.97% | -34.1% |
Q2 2017 | $12,172,000 | +731.4% | 130,000 | +465.2% | 4.50% | +421.1% |
Q1 2017 | $1,464,000 | -63.1% | 23,000 | -79.1% | 0.86% | -73.1% |
Q3 2016 | $3,966,000 | +92.7% | 110,000 | -26.7% | 3.21% | +56.8% |
Q2 2016 | $2,058,000 | – | 150,000 | – | 2.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |